Press Releases :: Inhibitor Therapeutics, Inc. (INTI)

Skip to main content Skip to section navigation Skip to footer

Aug 22, 2024 9:00 am EDT

Inhibitor Therapeutics, Inc. Provides Update on its Clinical Development Plan

Dec 19, 2023 10:00 am EST

Introducing Inhibitor Therapeutics, Inc. New Scientific Advisory Board

Dec 13, 2023 3:43 pm EST

Inhibitor Therapeutics, Inc. Exclusive License with Johns Hopkins University

Jan 22, 2020 8:05 am EST

INHIBITOR Therapeutics Receives prostate cancer IND Clearance from FDA

Nov 25, 2019 7:33 am EST

INHIBITOR Therapeutics Submits Investigational New Drug Application for Treatment of Patients with Late-Stage Prostate Cancer

Oct 31, 2019 8:55 am EDT

INHIBITOR Therapeutics Appoints Dr. Debra Peattie to its Board of Directors